Vadim Zotev Selected Research

Major Depressive Disorder (Major Depressive Disorders)

1/2021	Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorder.
1/2020	Effects of simultaneous real-time fMRI and EEG neurofeedback in major depressive disorder evaluated with brain electromagnetic tomography.
1/2020	Emotion self-regulation training in major depressive disorder using simultaneous real-time fMRI and EEG neurofeedback.
7/2018	Amygdala real-time functional magnetic resonance imaging neurofeedback for major depressive disorder: A review.
1/2018	Altered task-based and resting-state amygdala functional connectivity following real-time fMRI amygdala neurofeedback training in major depressive disorder.
10/2017	Real-Time Functional Magnetic Resonance Imaging Amygdala Neurofeedback Changes Positive Information Processing in Major Depressive Disorder.
1/2017	Randomized Clinical Trial of Real-Time fMRI Amygdala Neurofeedback for Major Depressive Disorder: Effects on Symptoms and Autobiographical Memory Recall.
1/2016	Correlation between amygdala BOLD activity and frontal EEG asymmetry during real-time fMRI neurofeedback training in patients with depression.
1/2014	Real-time FMRI neurofeedback training of amygdala activity in patients with major depressive disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vadim Zotev Research Topics

Disease

9	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2014
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 01/2018
2	Mental Disorders (Mental Disorder) 01/2019 - 01/2014
1	Anxiety Disorders (Anxiety Disorder) 01/2018

Drug/Important Bio-Agent (IBA)

1	KynurenineIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2018

Therapy/Procedure

14	Neurofeedback 01/2021 - 01/2014